logo

WW

WW·NASDAQ
--
--(--)
--
--(--)

WW fundamentals

WW (WW) released its earnings on Nov 6, 2025: revenue was 172.09M (YoY -10.79%), beat estimates; EPS was -5.76 (YoY -2500.00%), missed estimates.
Revenue / YoY
172.09M
-10.79%
EPS / YoY
-5.76
-2500.00%
Report date
Nov 6, 2025
WW Earnings Call Summary for Q3,2025
  • Clinical Growth: 35% YoY revenue increase, 60% YoY subscriber growth, and 19%-26% weight loss success rates.
  • Digital Transformation: 2026 app/website redesign to unify medical and behavioral programs with AI.
  • Partnerships: Amazon Pharmacy, NovoCare, and LillyDirect for medication access and delivery.
  • Menopause Program: Targets 1.3M U.S. women, with strong early engagement.
  • Challenges: Behavioral subscribers down 20% YoY, but improving from Q2 lows.
  • Upcoming Catalysts: Oral GLP-1 launch in early 2026 and peak season marketing push.
EPS
Revenue

Revenue & Expenses

WW has released its 2025 Q3 earnings report, with revenue of 172.09M, reflecting a YoY change of -10.78%, and net profit of -57.52M, showing a YoY change of -24.52%. The Sankey diagram below clearly presents WW's revenue sources and cost distribution.

Key Indicators

WW (WW) key financial stats and ratios, covering profitability, financial health, and leverage.
WW (WW)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
WW (WW)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
WW (WW)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does WW (WW) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track WW (WW) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield